Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.
Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M; Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Pitt B, et al. N Engl J Med. 2003 Apr 3;348(14):1309-21. doi: 10.1056/NEJMoa030207. Epub 2003 Mar 31. N Engl J Med. 2003. PMID: 12668699 Free article. Clinical Trial.
Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial.
Castagno D, Jhund PS, McMurray JJ, Lewsey JD, Erdmann E, Zannad F, Remme WJ, Lopez-Sendon JL, Lechat P, Follath F, Höglund C, Mareev V, Sadowski Z, Seabra-Gomes RJ, Dargie HJ. Castagno D, et al. Among authors: remme wj. Eur J Heart Fail. 2010 Jun;12(6):607-16. doi: 10.1093/eurjhf/hfq038. Epub 2010 Mar 30. Eur J Heart Fail. 2010. PMID: 20354032 Free article. Clinical Trial.
The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study.
Pitt B, Williams G, Remme W, Martinez F, Lopez-Sendon J, Zannad F, Neaton J, Roniker B, Hurley S, Burns D, Bittman R, Kleiman J. Pitt B, et al. Cardiovasc Drugs Ther. 2001 Jan;15(1):79-87. doi: 10.1023/a:1011119003788. Cardiovasc Drugs Ther. 2001. PMID: 11504167 No abstract available.
Evaluation of the functional status questionnaire in heart failure: a sub-study of the second cardiac insufficiency bisoprolol survival study (CIBIS-II).
Gallanagh S, Castagno D, Wilson B, Erdmann E, Zannad F, Remme WJ, Lopez-Sendon JL, Lechat P, Follath F, Höglund C, Mareev V, Sadowski Z, Seabra-Gomes RJ, Dargie HJ, McMurray JJ. Gallanagh S, et al. Among authors: remme wj. Cardiovasc Drugs Ther. 2011 Feb;25(1):77-85. doi: 10.1007/s10557-011-6284-x. Cardiovasc Drugs Ther. 2011. PMID: 21287410 Free article. Clinical Trial.
The safety of amiodarone in patients with heart failure.
Torp-Pedersen C, Metra M, Spark P, Lukas MA, Moullet C, Scherhag A, Komajda M, Cleland JG, Remme W, Di Lenarda A, Swedberg K, Poole-Wilson PA; COMET Investigators. Torp-Pedersen C, et al. J Card Fail. 2007 Jun;13(5):340-5. doi: 10.1016/j.cardfail.2007.02.009. J Card Fail. 2007. PMID: 17602979 Clinical Trial.
207 results